Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs072180082Completed
Randomised trial of betamethasone in hyperglycemia and insulin resistance (IR) (2 arms), sponsored by Nikkiso. Primary endpoint: insulin resistance. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs072180082.